Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1982 2
1983 1
1985 1
1986 3
1987 5
1989 6
1990 3
1991 6
1992 10
1993 2
1994 10
1995 13
1996 18
1997 11
1998 14
1999 22
2000 19
2001 25
2002 42
2003 47
2004 55
2005 68
2006 115
2007 105
2008 154
2009 155
2010 208
2011 239
2012 269
2013 302
2014 373
2015 449
2016 502
2017 569
2018 664
2019 723
2020 883
2021 952
2022 109
Text availability
Article attribute
Article type
Publication date

Search Results

6,431 results
Results by year
Filters applied: . Clear all
Page 1
International Classification of Retinopathy of Prematurity, Third Edition.
Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, Binenbaum G, Blair M, Peter Campbell J, Capone A Jr, Chen Y, Dai S, Ells A, Fleck BW, Good WV, Elizabeth Hartnett M, Holmstrom G, Kusaka S, Kychenthal A, Lepore D, Lorenz B, Martinez-Castellanos MA, Özdek Ş, Ademola-Popoola D, Reynolds JD, Shah PK, Shapiro M, Stahl A, Toth C, Vinekar A, Visser L, Wallace DK, Wu WC, Zhao P, Zin A. Chiang MF, et al. Among authors: zhao p. Ophthalmology. 2021 Oct;128(10):e51-e68. doi: 10.1016/j.ophtha.2021.05.031. Epub 2021 Jul 8. Ophthalmology. 2021. PMID: 34247850 Review.
HIF-1α promotes SARS-CoV-2 infection and aggravates inflammatory responses to COVID-19.
Tian M, Liu W, Li X, Zhao P, Shereen MA, Zhu C, Huang S, Liu S, Yu X, Yue M, Pan P, Wang W, Li Y, Chen X, Wu K, Luo Z, Zhang Q, Wu J. Tian M, et al. Among authors: zhao p. Signal Transduct Target Ther. 2021 Aug 18;6(1):308. doi: 10.1038/s41392-021-00726-w. Signal Transduct Target Ther. 2021. PMID: 34408131 Free PMC article.
Retraction notice to "LSAMP-AS1 binds to microRNA-183-5p to suppress the progression of prostate cancer by up-regulating the tumor suppressor DCN" [eBioMedicine 50 (2019) 178 - 190].
Hua X, Liu Z, Zhou M, Tian Y, Zhao PP, Pan WH, Li CX, Huang XX, Liao ZX, Xian Q, Chen B, Hu Y, Leng L, Fang XW, Yu LN. Hua X, et al. Among authors: zhao pp. EBioMedicine. 2021 Oct;72:103665. doi: 10.1016/j.ebiom.2021.103665. EBioMedicine. 2021. PMID: 34717838 Free PMC article. No abstract available.
ROS-Based Nanoparticles for Atherosclerosis Treatment.
Hu X, Zhao P, Lu Y, Liu Y. Hu X, et al. Among authors: zhao p. Materials (Basel). 2021 Nov 16;14(22):6921. doi: 10.3390/ma14226921. Materials (Basel). 2021. PMID: 34832328 Free PMC article. Review.
Immune Checkpoints: Therapeutic Targets for Pituitary Tumors.
Nie D, Xue Y, Fang Q, Cheng J, Li B, Wang D, Li C, Gui S, Zhang Y, Zhao P. Nie D, et al. Among authors: zhao p. Dis Markers. 2021 Aug 16;2021:5300381. doi: 10.1155/2021/5300381. eCollection 2021. Dis Markers. 2021. PMID: 34447484 Free PMC article. Review.
ALCAM-EGFR interaction regulates myelomagenesis.
Luo H, Zhang D, Wang F, Wang Q, Wu Y, Gou M, Hu Y, Zhang W, Huang J, Gong Y, Pan L, Li T, Zhao P, Zhang D, Qu Y, Liu Z, Jiang T, Dai Y, Guo T, Zhu J, Ye L, Zhang L, Liu W, Yi Q, Zheng Y. Luo H, et al. Among authors: zhao p. Blood Adv. 2021 Dec 14;5(23):5269-5282. doi: 10.1182/bloodadvances.2021004695. Blood Adv. 2021. PMID: 34592762 Free article.
Magneto-Endosomalytic Therapy for Cancer.
Zhao P, Han Y, Nguyen H, Corey E, Gao X. Zhao P, et al. Adv Healthc Mater. 2021 Aug 6:e2101010. doi: 10.1002/adhm.202101010. Online ahead of print. Adv Healthc Mater. 2021. PMID: 34355530
6,431 results